Immuno Technologies, Inc. is a US-based company that focuses on pre-clinical research on spirochetal diseases. With our main focus in Lyme diseases and Leptospirosis, we develop and license vaccines and diagnostic assays to help mitigate the impact of these diseases on human and animal health.